VIROLOGICAL BREAKTHROUGH IN CHRONIC HBV EGYPTIAN PATIENTS RECEIVING LAMIVUDINE THERAPY
Kamal Hassan Kamal;
Abstract
Background & Aim: The goal of therapy for hepatitis B is suppression of HBV replication in a sustained manner, thus preventing further progression of the disease. In HBeAg-negative chronic hepatitis B (CHB), Lamivudine is reported to be highly effective i
Other data
| Title | VIROLOGICAL BREAKTHROUGH IN CHRONIC HBV EGYPTIAN PATIENTS RECEIVING LAMIVUDINE THERAPY | Other Titles | المقاومة الڤيروسية لعقار اللاميڤيدين في المرضى المصريين المصابين بالإلتهاب الكبدي الڤيروسي (ب) المزمن | Authors | Kamal Hassan Kamal | Keywords | VIROLOGICAL BREAKTHROUGH IN CHRONIC HBV EGYPTIAN PATIENTS RECEIVING LAMIVUDINE THERAPY | Issue Date | 2012 | Description | Background & Aim: The goal of therapy for hepatitis B is suppression of HBV replication in a sustained manner, thus preventing further progression of the disease. In HBeAg-negative chronic hepatitis B (CHB), Lamivudine is reported to be highly effective i |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 111514R7477.pdf | 165.33 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.